NEWTOWN, Pa., May 16, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of specialized outsourced clinical trial services and eClinical Solutions, previewed several new enhancements to its eClinical Solutions suite during the annual BioClinica Global User Conference held May 5-7 in Philadelphia. Nearly 200 industry professionals participated in more than 30 sessions including demonstrations, case studies, and panel discussions.
The conference provided BioClinica's international user base an interactive forum to engage with product developers, project managers, IT, data management specialists and each other. "The conference was a huge success and we are thankful to all who participated," BioClinica President of eClinical Solutions Peter Benton commented. "Participants brought us their challenges and opportunities and shared their successes in leveraging the BioClinica platform for faster, more efficient clinical trials." Lori Convy, Clinical Research Monitoring, Sanofi, delivered a joint keynote address with Courtney McBean, President, Blueprint Clinical, on Risk-Based Monitoring. The presentation underscored BioClinica's industry-leading Risk-Based Monitoring strategy and the benefits of adopting such an approach. On day two of the conference, former FDA Chief Information Officer, Eric Perakslis, PhD, Executive Director Center for Biomedical Informatics, Harvard Medical School, delivered the keynote address, 'Data Science against Disease'.
Product enhancements previewed at the conference encompass BioClinica's OnPoint CTMS, Express EDC, Trident IRT, and clinical supplies Optimizer. Several new features augment BioClinica's already robust Microsoft-Smart global CTMS, including electronic submissions via ClinicalTrials.gov; single sign on across multiple products; Sunshine Act compliance reporting support; and a new look and feel to the User Interface.
An Express EDC app for Windows tablets is among the new offerings, enabling easy data collection in an eSource solution. The Express Kiosk app was also introduced, which allows patients to electronically report outcomes at home or in a clinic setting instead of filling out paper questionnaires.
Also at the conference, attendees got a first look at the Optimizer Enterprise Suite. It makes BioClinica's advanced clinical supplies forecasting, simulation and demand planning technology available in a streamlined web version in addition to its original desktop solution. Lastly, BioClinica introduced expanded functionality in its parameter-driven Trident IRT, giving customers greater control over their clinical studies.
Industry professionals can get a look at BioClinica's eClinical Solutions and learn more them and its industry-leading Medical Imaging and Cardiac Safety services at several upcoming events. The Company is exhibiting, speaking at, or participating in the following:
- Outsourcing in Clinical Trials Europe 2014, Brussels, Belgium, May 21-24, Booth 39
- 8th DIA Annual Conference in Japan for Asian New Drug Development, Tokyo, Japan, May 22-23
- American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago, IL, May 30-June 3, Booth 6109
- Pharmaceutical Contract Management Group 10th Annual Conference, Lisbon, Portugal, June 4-6
- Drug Information Association (DIA), 50th Annual Meeting, San Diego, CA, June 15-19, Booth 1725, BioClinica IRT Project Manager John Burns my Rupp will be speaking on Drug Shortages in Clinical Trials as part of the clinical supply symposium on June 18, from 10:30 AMNoon
- International Workshop on Osteoarthritis Imaging (IWOAI),Reykjavik, Iceland, July 9-12
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for electronic data capture (EDC), randomization (IRT), clinical trial management (CTMS), and clinical trial supply management, forecasting and optimization (CTSM). BioClinica's Imaging and Cardiovascular division offers unmatched scientific expertise with its team of respected medical researchers; electronic transfer, management, and independent review of medical images; plus cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis. With more than 29 years of experience and over 4000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on three continents, and supports worldwide eClinical, comprehensive cardiovascular safety, and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.
Photo - http://photos.prnewswire.com/prnh/20140516/88366
Logo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
SOURCE BioClinica, Inc.